Switch to:

Stemline Therapeutics Inc (STML)Ownership Data

Short Interest History (%)

This is the historical short interest of Stemline Therapeutics Inc, as measured by the Short Percentage Of Float.

Date Short Interest
January 30, 20158.78
January 15, 20158.15
December 31, 20149.85
December 15, 201411.44
November 28, 201411.63
November 14, 201411.48
October 31, 201410.61
October 15, 201410.59
September 30, 20149.24
September 15, 20149.8
August 29, 20149.33
August 15, 20149.11
July 31, 20149.01
July 15, 20148.82
June 30, 20148.55
June 13, 20149.41
May 30, 20149.95
May 15, 20149.53
April 30, 20148.94
April 15, 201413.28
March 31, 201412.98
March 14, 201412.99
February 28, 201411.85
February 14, 201412.59
January 31, 20149.44
January 15, 20147.47
December 31, 20137.4
December 13, 20137.97
November 29, 20138.32
November 15, 20137.77
October 31, 20137.71
October 15, 20137.77
September 30, 20138.65
September 13, 201310.81
August 30, 201312.98
August 15, 201314.74
July 31, 201315.5
July 15, 201316.78
June 28, 20135.43
June 14, 20133.81
May 31, 20131.41
May 15, 20131.9
April 30, 20132.12
April 15, 20132.36
March 28, 20132.33
March 15, 20132.15
February 28, 20131.92
February 15, 20131.68
January 31, 20130.78

Institutional Ownership History (%)

This the Institutional Ownership History of Stemline Therapeutics IncPeter Lynch prefers to buy companies with low institutional ownership.

Date Institutional Ownership
January 31, 201560
December 31, 201460
November 30, 201461
October 31, 201461
September 30, 201466
August 31, 201470
July 31, 201471
June 30, 201477
May 31, 201477
April 30, 201477
March 31, 201471
February 28, 201476
January 31, 201475
December 31, 201371
November 30, 201364
October 31, 201363
September 30, 201369
August 31, 201369
July 31, 201369
June 30, 201321
May 31, 201333
April 30, 201353
March 31, 201310
February 28, 201311

Insider ownership (%)

This is the historical insider ownership of Stemline Therapeutics Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Date Insider Ownership
January 31, 201517
December 31, 201416
November 30, 201417
October 31, 201417
September 30, 201417
August 31, 201417
July 31, 201417
June 30, 201417
May 31, 201417

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Ivan BergsteinCEO, 10% Owner1,888,80114.22%2015-02-18
Dr. Eric K. Rowinsky,M.D.Chief Medical Officer130,1330.98%2015-02-18
Mr. Kenneth HobermanCOO87,9420.66%2015-02-18
Stephen P. HallN/A40,0000.3%2013-06-19
Mr. David G. GioncoChief Accounting Officer26,6890.2%2015-01-20
Mr. J. Kevin BuchiDirector13,7720.1%2013-01-29
Mr. Kenneth J. ZuerblisDirector11,963less than 0.1%2014-09-02
Eric L. DobmeierN/A7,963less than 0.1%2013-01-28
Ron BentsurN/A3,252less than 0.1%2013-01-28

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value
Fidelity Management and Research Company1,640,8922015-02-1312.350.0025,401,008
Fidelity® Select Biotechnology Portfolio1,243,3992014-12-319.360.1921,212,387
Franklin Advisers, Inc.971,7302014-12-317.320.0116,578,000
TimesSquare Capital Management, LLC840,3802014-12-316.330.0814,337,000
Franklin Biotechnology Discovery617,3302014-10-314.650.379,500,709
Eventide Asset Management, LLC600,5002014-12-314.521.1210,245,000
Eventide Gilead Fund435,5002014-09-303.280.745,426,330
Goldman Sachs Asset Management, L.P.424,6342014-12-313.200.017,244,000
Goldman Sachs Small/Mid Cap Growth Fund403,1322014-12-313.040.296,877,432
VHCP Management, LLC356,4002014-12-312.681.606,080,000

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK